Join
Live feed
·
INSIDERFilingvia Quantisnow
NovaBay Pharmaceuticals Inc. logo

Chief Executive Officer Kazley Michael John converted options into 56,806,080 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NBY· NovaBay Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBY (NovaBay Pharmaceuticals Inc.) and more on Quantisnow.